- Home
- PLRX vs KIDS Comparison
PLRX vs KIDS Comparison
Compare PLRX & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | KIDS |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 49 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.1M | 401.2M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PLRX | KIDS |
|---|---|---|
| Price | $1.31 | $15.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $2.67 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 552.8K | 155.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $98,049,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | N/A | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.95 |
| 52 Week Low | $1.09 | $14.91 |
| 52 Week High | $1.95 | $23.70 |
Technical Indicators
Market Signals| Indicator | PLRX | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 42.40 |
| Support Level | $1.12 | $15.98 |
| Resistance Level | $1.36 | $19.15 |
| Average True Range (ATR) | 0.07 | 0.78 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 70.83 | 35.79 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.